158 related articles for article (PubMed ID: 31289932)
1. Sudden unexpected cardiac death and postmortem identification of a novel RYR2 gene mutation.
Mahlke N; Dittmann S; Schulze-Bahr E; Ritz-Timme S; Hartung B
Int J Legal Med; 2019 Nov; 133(6):1835-1838. PubMed ID: 31289932
[TBL] [Abstract][Full Text] [Related]
2. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
[TBL] [Abstract][Full Text] [Related]
3. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.
Arakawa J; Hamabe A; Aiba T; Nagai T; Yoshida M; Touya T; Ishigami N; Hisadome H; Katsushika S; Tabata H; Miyamoto Y; Shimizu W
Heart Vessels; 2015 Nov; 30(6):835-40. PubMed ID: 25092222
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
[TBL] [Abstract][Full Text] [Related]
5. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest.
Campbell MJ; Czosek RJ; Hinton RB; Miller EM
Am J Med Genet A; 2015 Sep; 167A(9):2197-200. PubMed ID: 26018045
[TBL] [Abstract][Full Text] [Related]
6. Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation.
Itoh H; Murayama T; Kurebayashi N; Ohno S; Kobayashi T; Fujii Y; Watanabe M; Ogawa H; Anzai T; Horie M
J Electrocardiol; 2021; 69():111-118. PubMed ID: 34656916
[TBL] [Abstract][Full Text] [Related]
7. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases.
Tester DJ; Spoon DB; Valdivia HH; Makielski JC; Ackerman MJ
Mayo Clin Proc; 2004 Nov; 79(11):1380-4. PubMed ID: 15544015
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.
Wangüemert F; Bosch Calero C; Pérez C; Campuzano O; Beltran-Alvarez P; Scornik FS; Iglesias A; Berne P; Allegue C; Ruiz Hernandez PM; Brugada J; Pérez GJ; Brugada R
Heart Rhythm; 2015 Jul; 12(7):1636-43. PubMed ID: 25814417
[TBL] [Abstract][Full Text] [Related]
9. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
[TBL] [Abstract][Full Text] [Related]
10. A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
Roston TM; Guo W; Krahn AD; Wang R; Van Petegem F; Sanatani S; Chen SR; Lehman A
J Electrocardiol; 2017; 50(2):227-233. PubMed ID: 27646203
[TBL] [Abstract][Full Text] [Related]
11. Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates.
d'Amati G; Bagattin A; Bauce B; Rampazzo A; Autore C; Basso C; King K; Romeo MD; Gallo P; Thiene G; Danieli GA; Nava A
Hum Pathol; 2005 Jul; 36(7):761-7. PubMed ID: 16084945
[TBL] [Abstract][Full Text] [Related]
12. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
Nof E; Belhassen B; Arad M; Bhuiyan ZA; Antzelevitch C; Rosso R; Fogelman R; Luria D; El-Ani D; Mannens MM; Viskin S; Eldar M; Wilde AA; Glikson M
Heart Rhythm; 2011 Oct; 8(10):1546-52. PubMed ID: 21699856
[TBL] [Abstract][Full Text] [Related]
13. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
Medeiros-Domingo A; Bhuiyan ZA; Tester DJ; Hofman N; Bikker H; van Tintelen JP; Mannens MM; Wilde AA; Ackerman MJ
J Am Coll Cardiol; 2009 Nov; 54(22):2065-74. PubMed ID: 19926015
[TBL] [Abstract][Full Text] [Related]
14. Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death.
Zhong X; Guo W; Wei J; Tang Y; Liu Y; Zhang JZ; Tan VH; Zhang L; Wang R; Jones PP; Napolitano C; Priori SG; Chen SRW
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825858
[TBL] [Abstract][Full Text] [Related]
15. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.
Tester DJ; Kopplin LJ; Will ML; Ackerman MJ
Heart Rhythm; 2005 Oct; 2(10):1099-105. PubMed ID: 16188589
[TBL] [Abstract][Full Text] [Related]
16. Ryanodine receptor mutations presenting as idiopathic ventricular fibrillation: a report on two novel familial compound mutations, c.6224T>C and c.13781A>G, with the clinical presentation of idiopathic ventricular fibrillation.
Paech C; Gebauer RA; Karstedt J; Marschall C; Bollmann A; Husser D
Pediatr Cardiol; 2014 Dec; 35(8):1437-41. PubMed ID: 24950728
[TBL] [Abstract][Full Text] [Related]
17. Cardiac ryanodine receptor gene (hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope.
Mok NS; Lam CW; Fong NC; Hui YW; Choi YC; Chan KY
Chin Med J (Engl); 2006 Dec; 119(24):2129-33. PubMed ID: 17199967
[No Abstract] [Full Text] [Related]
18. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
Xiong J; Liu X; Gong Y; Zhang P; Qiang S; Zhao Q; Guo R; Qian Y; Wang L; Zhu L; Wang R; Hao Z; Wen H; Zhang J; Tang K; Zang WF; Yuchi Z; Chen H; Chen SRW; Zheng W; Wang SQ; Xu YW; Liu Z
J Mol Cell Cardiol; 2018 Apr; 117():26-35. PubMed ID: 29477366
[TBL] [Abstract][Full Text] [Related]
19. The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry.
Roston TM; Yuchi Z; Kannankeril PJ; Hathaway J; Vinocur JM; Etheridge SP; Potts JE; Maginot KR; Salerno JC; Cohen MI; Hamilton RM; Pflaumer A; Mohammed S; Kimlicka L; Kanter RJ; LaPage MJ; Collins KK; Gebauer RA; Temple JD; Batra AS; Erickson C; Miszczak-Knecht M; Kubuš P; Bar-Cohen Y; Kantoch M; Thomas VC; Hessling G; Anderson C; Young ML; Choi SHJ; Cabrera Ortega M; Lau YR; Johnsrude CL; Fournier A; Van Petegem F; Sanatani S
Europace; 2018 Mar; 20(3):541-547. PubMed ID: 28158428
[TBL] [Abstract][Full Text] [Related]
20. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.
Nozaki Y; Kato Y; Uike K; Yamamura K; Kikuchi M; Yasuda M; Ohno S; Horie M; Murayama T; Kurebayashi N; Horigome H
Circ J; 2020 Jan; 84(2):226-234. PubMed ID: 31875585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
